David JIANG, MD, PhD
- Jiahui International Cancer Center
- Medical Oncology
- Cancer Pain Management Clinic
- Medical Oncology（Solid Tumor）
- Cancer Center (Follow-up Consultation Only)
- Hepatobiliary Tumor MDT Clinic
- Colorectal Tumor MDT Clinic
- Jiahui International Hospital (Shanghai)
- Languages:普通话, English
Dr. David JIANG，Medical Doctor, associate chief physician, associate professor. Dr. Jiang graduated from Fudan Universty. Before joining Jiahui Health, Dr. Jiang has worked more than a decade in Huashan Hospital, Fudan University.
Dr. Jiang was occupied mainly with the chemotherapy, targeted therapy, immunotherapy, vascular interventional treatment of malignant solid tumor (TACE, HAIC) and PORT implantation. He has accumulated rich experience in comprehensive therapy of solid tumor, such as colorectal cancer, gastric cancer, primary and secondary liver cancer, pancreatic cancer, gallbladder cancer, esophageal cancer, lung cancer, tumors of the genitourinary system and head and neck. He has also accumulated some experience on rare malignant tumor. Dr. Jiang devotes himself to Evidence-based Medicine, and individualized precise diagnosis and treatment. He also always pays attention to symptom management (including cancer pain, nutritional support, prevention of chemotherapy induced nausea and vomiting), whole-process management and humanistic care for patients with tumor.
He has presided over and taken part in several national natural science foundation of China (NSFC). He was also supported by the fund of the first session training program for young doctors of Shanghai City and HuaJing award of Huashan hospital, Fudan University, which encourages excellent attending physician. As the first author, he has published more than 10 peer-reviewed papers in SCI Journals such as Journal of Thoracic Oncology, Lung Cancer and Cancer Medicine. Three of these papers were cited by four Clinical Practice Guidelines or Expert Consensus published by American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO) and American College of Chest Physicians (ACCP).
Dr. Jiang is a committee member of Precision Medicine Expert Committee of Shanghai Biomedical Industry Association, and a committee member of the first session of Vascular Access Expert Committee of Solid Tumor Focus Diagnosis and Treatment Specialized Committee of Shanghai Anticancer Association. He is also a current member of ASCO，ESMO, CSCO and Chinese Medical Association.